NUMORPHAN Trademark

Trademark Overview

On Thursday, February 24, 1994, a trademark application was filed for NUMORPHAN with the United States Patent and Trademark Office. The USPTO has given the NUMORPHAN trademark a serial number of 74494055. The federal status of this trademark filing is REGISTERED AND RENEWED as of Friday, September 25, 2015. This trademark is owned by DuPont Merck Pharmaceutical Company, The. The NUMORPHAN trademark is filed in the Pharmaceutical Products category with the following description:

general analgesic
numorphan

General Information

Serial Number74494055
Word MarkNUMORPHAN
Filing DateThursday, February 24, 1994
Status800 - REGISTERED AND RENEWED
Status DateFriday, September 25, 2015
Registration Number1936442
Registration DateTuesday, November 21, 1995
Mark Drawing1 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, August 29, 1995

Trademark Statements

Goods and Servicesgeneral analgesic

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes018
Class Status Code6 - Active
Class Status DateThursday, April 28, 1994
Primary Code005
First Use Anywhere DateSaturday, October 1, 1949
First Use In Commerce DateSaturday, October 1, 1949

Trademark Owner History

Party NameENDO OPERATIONS LIMITED
Party Type41 - New Owner After Registration
Legal Entity Type24 - NOT AVAILABLE
AddressBALLSBRIDGE 4
IE
Party NameENDO PHARMACEUTICALS, INC.
Party Type40 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressCHADDS FOOD, PA 19317
Party NameDuPont Merck Pharmaceutical Company, The
Party Type30 - Original Registrant
Legal Entity Type02 - Partnership
AddressWilmington, DE 19805
Party NameDuPont Merck Pharmaceutical Company, The
Party Type20 - Owner at Publication
Legal Entity Type02 - Partnership
AddressWilmington, DE 19805
Party NameDuPont Merck Pharmaceutical Company, The
Party Type10 - Original Applicant
Legal Entity Type02 - Partnership
AddressWilmington, DE 19805

Trademark Events

Event DateEvent Description
Friday, July 28, 1995NOTICE OF PUBLICATION
Saturday, July 23, 1994ASSIGNED TO EXAMINER
Wednesday, July 27, 1994NON-FINAL ACTION MAILED
Monday, January 23, 1995CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, March 16, 1995APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 20, 2011ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Tuesday, August 29, 1995PUBLISHED FOR OPPOSITION
Tuesday, November 21, 1995REGISTERED-PRINCIPAL REGISTER
Monday, December 11, 2000REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
Wednesday, March 28, 2001REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Monday, January 10, 2005PAPER RECEIVED
Monday, January 10, 2005REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED
Tuesday, March 1, 2005REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Tuesday, March 1, 2005REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Wednesday, December 15, 2010ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Wednesday, March 12, 2014ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Wednesday, March 26, 2014ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Thursday, June 25, 2015TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, June 25, 2015ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, December 22, 2021ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Wednesday, May 1, 2024AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Monday, August 24, 2015TEAS SECTION 8 & 9 RECEIVED
Monday, September 21, 2015CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, September 25, 2015REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Friday, September 25, 2015REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
Friday, September 25, 2015NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Friday, June 28, 2024ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

Related Keywords

numorphan analgesic general